2025
Novel F-18-labeled Tracers of Sympathetic Function for Improved Risk Stratification and Clinical Outcomes
Zohora F, Nazari M, Sinusas A. Novel F-18-labeled Tracers of Sympathetic Function for Improved Risk Stratification and Clinical Outcomes. Current Cardiology Reports 2025, 27: 61. PMID: 40009333, DOI: 10.1007/s11886-025-02197-9.Peer-Reviewed Original ResearchConceptsSudden cardiac deathImplantable cardioverter defibrillatorPositron emission tomographyImplantable cardioverter defibrillator placementMyocardial sympathetic denervationRisk stratificationSympathetic denervationIschemic heart diseaseHeart failurePrevention of sudden cardiac deathRisk stratification of patientsHeart diseaseOptimal risk stratificationLow ejection fractionStratification of patientsSympathetic nerve densityImprove risk stratificationHeart failure patientsPositron emission tomography radiotracersPredicting sudden cardiac deathPositron emission tomography tracersPrognostic benefitEjection fractionClinically practical approachNerve density
2024
Long-Term Outcomes of Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Use Among Patients on Maintenance Dialysis
Pun P, Qin L, Minges K, Al-Khatib S, Friedman D. Long-Term Outcomes of Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Use Among Patients on Maintenance Dialysis. Heart Rhythm 2024 PMID: 39615818, DOI: 10.1016/j.hrthm.2024.11.050.Peer-Reviewed Original ResearchHospital admissionAccess interventionsAssociated with decreased riskFee-for-serviceLongitudinal cohort studyMedicare claims dataAssociated with decreased risk of deathImplantable cardioverter defibrillator useNational Cardiovascular Data Registry ICD RegistryBurden of cardiac diseaseRisk of deathDialysis access interventionsDefibrillator useClaims dataElevated risk of sudden cardiac deathImplantable cardioverter defibrillatorLong-term outcomesRisk of sudden cardiac deathStabilized inverse probabilityDialysis patientsElevated riskInclusion criteriaTV-ICDS-ICDICD RegistryMachine Learning-Based Prediction of Death and Hospitalization in Patients With Implantable Cardioverter Defibrillators
Rosman L, Lampert R, Wang K, Gehi A, Dziura J, Salmoirago-Blotcher E, Brandt C, Sears S, Burg M. Machine Learning-Based Prediction of Death and Hospitalization in Patients With Implantable Cardioverter Defibrillators. Journal Of The American College Of Cardiology 2024, 85: 42-55. PMID: 39570241, DOI: 10.1016/j.jacc.2024.09.006.Peer-Reviewed Original ResearchImplantable cardioverter-defibrillatorYear of device implantationAll-cause mortalityCardiac resynchronization therapyDeath/HF hospitalizationValidation cohortHeart failureDevice implantationTime of ICD implantationArea under the receiver-operating characteristic curveMedian follow-upReceiver-operating characteristic curvePredicting all-cause mortalityImplantable cardioverter-defibrillator patientsVeterans Health AdministrationPersonalized risk estimatesImplantable cardioverter defibrillatorResynchronization therapyBaseline demographicsICD implantationTraining cohortTrajectories of individual patientsProspective studyComposite outcomeContinuum of riskEfficacy and safety of implantable cardioverter-defibrillator implantation in the elderly—The I-70 Study: A randomized clinical trial
Singh S, Wininger M, Raitt M, Adabag S, Moore H, Rottman J, Scrymgeour A, Zhang J, Zheng K, Guarino P, Kyriakides T, Group I, Johnson G, Williams A, Beed A, MacMurdy K, Saavedra P. Efficacy and safety of implantable cardioverter-defibrillator implantation in the elderly—The I-70 Study: A randomized clinical trial. Heart Rhythm O2 2024, 5: 365-373. PMID: 38984364, PMCID: PMC11228113, DOI: 10.1016/j.hroo.2024.04.010.Peer-Reviewed Original ResearchImplantable cardioverter defibrillatorParticipant follow-upPatient treatment preferencesICD implantationFollow-upTarget sample sizeAll-cause hospitalizationsPrimary prevention ICD implantationMonths of follow-upImplantable cardioverter defibrillator therapySafety of implantable cardioverter defibrillatorsImplantable cardioverter defibrillator implantationOptimal medical therapyRate of sudden deathTreatment preferencesImplantable cardioverter defibrillator shocksSafety of ICD implantationConfidence intervalsStudy protocolMedical therapyParticipantsProlonging lifePatientsSudden deathCardioverter defibrillatorDevices and Athletics Decision-Making Around Return to Play
Kay B, Lampert R. Devices and Athletics Decision-Making Around Return to Play. Cardiac Electrophysiology Clinics 2024, 16: 81-92. PMID: 38280816, DOI: 10.1016/j.ccep.2023.09.009.Peer-Reviewed Original ResearchConceptsSports participationSafety of sports participationSports-related deathsEmergency action planImplantable cardioverter defibrillatorAthletic cohortObservational registry dataCompetitive athletesAthletic activityRegistry dataAthletesExternal resuscitationOptimization of medical therapyAction planSocietal recommendationsSportsParticipantsCardioverter defibrillatorMedical therapyResuscitationCohortDevice settingsInappropriate shocksRecommendationsDefibrillationSafety of Sports for Patients with Subcutaneous Implantable Cardioverter Defibrillator (SPORT S-ICD): study rationale and protocol
Chorin E, Lampert R, Bijsterveld N, Knops R, Wilde A, Heidbuchel H, Krahn A, Goldenberg I, Rosso R, Viskin D, Frydman S, Lupu L, Viskin S. Safety of Sports for Patients with Subcutaneous Implantable Cardioverter Defibrillator (SPORT S-ICD): study rationale and protocol. Heart Rhythm O2 2024, 5: 182-188. PMID: 38560377, PMCID: PMC10980925, DOI: 10.1016/j.hroo.2024.01.007.Peer-Reviewed Original ResearchSports participationSafety of sports participationContinuation of sportsSports activitiesSafety of sportsReturn to sportShared-decision makingImplantable cardioverter defibrillatorCompetitive sportsSportsClinical decision-makingBaseline assessmentTesting hypothesesStudy coordinatorsDecision-makingStudy rationaleObservational studyParticipantsAthletesBaseline characteristicsNon-interventionalSubcutaneous implantable cardioverter defibrillatorS-ICDSafetyS-ICD system
2023
Efficacy of a web-based healthcare innovation to advance the quality of life and care of patients with an implantable cardioverter defibrillator (ACQUIRE-ICD): a randomized controlled trial
Skov O, Johansen J, Nielsen J, Larroudé C, Riahi S, Melchior T, Vinther M, Skovbakke S, Rottmann N, Wiil U, Brandt C, Smolderen K, Spertus J, Pedersen S. Efficacy of a web-based healthcare innovation to advance the quality of life and care of patients with an implantable cardioverter defibrillator (ACQUIRE-ICD): a randomized controlled trial. EP Europace 2023, 25: euad253. PMID: 38055845, PMCID: PMC10700011, DOI: 10.1093/europace/euad253.Peer-Reviewed Original ResearchConceptsWeb-based interventionUsual careDevice acceptanceFlorida Patient Acceptance SurveySymptoms of anxietyCare of patientsSymptoms of depressionQuality of lifeImplantable cardioverter defibrillatorImplantable cardioverter defibrillator patientsRandomized controlled trialsFirst-time ICD recipientsOnline patient forumsRemote device monitoringImplant centresPsychological interventionsHealthcare innovationAcceptability surveyStandard interventionGoal settingAnxiety symptomsPatient forumsCareInterventionNon-blindedVigorous Exercise in Patients With Hypertrophic Cardiomyopathy
Lampert R, Ackerman M, Marino B, Burg M, Ainsworth B, Salberg L, Tome Esteban M, Ho C, Abraham R, Balaji S, Barth C, Berul C, Bos M, Cannom D, Choudhury L, Concannon M, Cooper R, Czosek R, Dubin A, Dziura J, Eidem B, Emery M, Estes N, Etheridge S, Geske J, Gray B, Hall K, Harmon K, James C, Lal A, Law I, Li F, Link M, McKenna W, Molossi S, Olshansky B, Ommen S, Saarel E, Saberi S, Simone L, Tomaselli G, Ware J, Zipes D, Day S, Abrahms D, Ashley E, Aziz P, Batra A, Cerrone M, Colan S, Erickson C, Ferhaan A, Gollob M, Johnsrude C, Kannankeril P, Kanter R, Li W, Masri A, Murphy A, Nandi D, Perez M, Perry J, Popjes E, Rao R, Rosenthal D, Sanatani S, Semsarian C, Shah M, Skinner J, Tardif J, Towbin J, Turer A, Webster G, Wever-Pinzon O, Wong T. Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy. JAMA Cardiology 2023, 8: 595-605. PMID: 37195701, PMCID: PMC10193262, DOI: 10.1001/jamacardio.2023.1042.Peer-Reviewed Original ResearchConceptsComposite end pointVigorous-intensity exerciseHypertrophic cardiomyopathyVigorous exerciseEnd pointCohort studyExercise categoriesVentricular arrhythmiasPhysical activityPrimary composite end pointMultivariate Cox regression analysisAdjusted hazard ratioProspective cohort studyCox regression analysisLeft ventricular hypertrophyLife-threatening arrhythmiasSudden cardiac arrestImplantable cardioverter defibrillatorHigh rateHCM centersNonvigorous activitiesObservational registryAppropriate shocksExperienced centersHazard ratio
2022
Devices and Athletics Decision-Making Around Return to Play
Kay B, Lampert R. Devices and Athletics Decision-Making Around Return to Play. Cardiology Clinics 2022, 41: 81-92. PMID: 36368813, DOI: 10.1016/j.ccl.2022.08.007.ChaptersConceptsImplantable cardioverter defibrillatorObservational registry dataSports-related deathsSports participationMedical therapyInappropriate shocksRegistry dataCardioverter defibrillatorSocietal recommendationsAthletic activityAthlete cohortCompetitive athleticsEmergency action planAthletesDevice settingsContraindicationsResuscitationTherapyCohortDefibrillatorCardiac Status Among Heart Failure Patients With Implantable Cardioverter Defibrillators Before, During, and After COVID-19 Lockdown
Lu Y, Jones PW, Murugiah K, Caraballo C, Mahajan S, Massey D, Ahmed R, Bader E, Krumholz H. Cardiac Status Among Heart Failure Patients With Implantable Cardioverter Defibrillators Before, During, and After COVID-19 Lockdown. Journal Of Cardiac Failure 2022, 28: 1372-1374. PMID: 35690314, PMCID: PMC9187866, DOI: 10.1016/j.cardfail.2022.05.012.Peer-Reviewed Original ResearchConceptsImplantable cardioverter defibrillatorHeart failure patientsCRT-D devicesCardiac statusFailure patientsHeart failureCardioverter defibrillatorCardiac resynchronization therapy defibrillatorAcute cardiac conditionsMedical care deliveryInpatient careCardiac conditionsPhysiologic markersInpatient servicesPatientsCardiac healthCare deliveryMarked restrictionImplanted ICDsMinneapolis/Saint PaulSex subgroupsDefibrillatorCOVID-19Telemedicine servicesCOVID-19 lockdownLongitudinal Outcomes of Subcutaneous or Transvenous Implantable Cardioverter-Defibrillators in Older Patients
Friedman DJ, Qin L, Parzynski C, Heist EK, Russo AM, Ranasinghe I, Zeitler EP, Minges KE, Akar JG, Freeman JV, Curtis JP, Al-Khatib SM. Longitudinal Outcomes of Subcutaneous or Transvenous Implantable Cardioverter-Defibrillators in Older Patients. Journal Of The American College Of Cardiology 2022, 79: 1050-1059. PMID: 35300816, DOI: 10.1016/j.jacc.2021.12.033.Peer-Reviewed Original ResearchConceptsOlder patientsCause readmissionS-ICDNational Cardiovascular Data Registry ICD RegistryDevice removalTransvenous implantable cardioverter defibrillatorTV-ICD patientsRisk of deathS-ICD patientsService Medicare beneficiariesAnderson-Gill modelsImplantable cardioverter defibrillatorRepresentative national cohortCompeting-risks modelTV-ICDCardiovascular readmissionCause mortalityICD implantationYounger patientsICD RegistryNonfatal outcomesTransvenous ICDAtrial fibrillationNational cohortCardioverter defibrillatorTrends in Use of Single- vs Dual-Chamber Implantable Cardioverter-Defibrillators Among Patients Without a Pacing Indication, 2010-2018
Borne RT, Varosy P, Lan Z, Masoudi FA, Curtis JP, Matlock DD, Peterson PN. Trends in Use of Single- vs Dual-Chamber Implantable Cardioverter-Defibrillators Among Patients Without a Pacing Indication, 2010-2018. JAMA Network Open 2022, 5: e223429. PMID: 35315917, PMCID: PMC8941353, DOI: 10.1001/jamanetworkopen.2022.3429.Peer-Reviewed Original ResearchConceptsDual-chamber ICDFirst-time ICD implantationPacing indicationICD implantationMedian odds ratioPatient characteristicsOdds ratioAtrial leadNational Cardiovascular Data Registry ICD RegistryCardiac resynchronization therapy indicationDual-chamber ICD implantationMulticenter cross-sectional studyBradycardia pacing indicationSingle-chamber ICDHospital-level variationHigh procedural riskCross-sectional studyLow-value practicesImplantable cardioverter defibrillatorLow-value careCochran-Armitage trend testImplantable cardioverter-defibrillator systemsDual-chamber devicesCardioverter-defibrillator systemsReal-world practiceCurrent Practices in Treating Cardiomyopathy and Heart Failure in Duchenne Muscular Dystrophy (DMD): Understanding Care Practices in Order to Optimize DMD Heart Failure Through ACTION
Villa C, Auerbach SR, Bansal N, Birnbaum BF, Conway J, Esteso P, Gambetta K, Hall EK, Kaufman BD, Kirmani S, Lal AK, Martinez HR, Nandi D, O’Connor M, Parent JJ, Raucci FJ, Shih R, Shugh S, Soslow JH, Tunuguntla H, Wittlieb-Weber CA, Kinnett K, Cripe L. Current Practices in Treating Cardiomyopathy and Heart Failure in Duchenne Muscular Dystrophy (DMD): Understanding Care Practices in Order to Optimize DMD Heart Failure Through ACTION. Pediatric Cardiology 2022, 43: 977-985. PMID: 35024902, PMCID: PMC8756173, DOI: 10.1007/s00246-021-02807-7.Peer-Reviewed Original ResearchConceptsVentricular assist deviceDuchenne muscular dystrophyHeart failureTherapeutic approachesAdvanced Cardiac Therapies Improving Outcomes NetworkDMD patientsBeta-blocker therapyMuscular dystrophyImplantable cardioverter defibrillatorAldosterone antagonistsSystolic dysfunctionCardiology providersHolter monitoringPrimary preventionDestination therapyPediatric cardiologistsCardiac careLeading causeOutcomes NetworkCardioverter defibrillatorCardiac diseaseClinical careMuscle therapyEnzyme inhibitorsCare practices
2021
2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients: Executive summary
Members W, Silka MJ, Shah MJ, Silva J, Balaji S, Beach C, Benjamin M, Berul C, Cannon B, Cecchin F, Cohen M, Dalal A, Dechert B, Foster A, Gebauer R, Corcia M, Kannankeril J, Karpawich P, Kim J, Krishna MR, Kubuš P, LaPage M, Mah D, Malloy-Walton L, Miyazaki A, Motonaga K, Niu M, Olen M, Paul T, Rosenthal E, Saarel E, Silvetti MS, Stephenson E, Tan R, Triedman J, Von Bergen N, Wackel P, Reviewers D, Chang P, Drago F, Dubin A, Etheridge S, Kongpatanayothin A, Moltedo J, Nabar A, Van Hare G. 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients: Executive summary. Indian Pacing And Electrophysiology Journal 2021, 21: 349-366. PMID: 34333142, PMCID: PMC8577082, DOI: 10.1016/j.ipej.2021.07.006.Peer-Reviewed Original ResearchCardiac implantable electronic devicesExpert consensus statementYears of ageImplantable cardioverter defibrillatorPediatric patientsImplantable electronic devicesConsensus statementACC/AHA/HRSCardiac conduction delayManagement of patientsAge-specific thresholdsCardiovascular implantable electronic devicesYounger patientsPractice guidelinesCardioverter defibrillatorCardiac pacingConduction delayElectronic searchPatientsPhysiologic parametersHeart rhythmDiagnostic categoriesSupportive textAgeFurther dataLongitudinal Outcomes Associated With Non-Evidence-Based Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries (From the National Cardiovascular Data Registry)
Daimee UA, Aslam F, Parzynski CS, Desai NR, Curtis JP. Longitudinal Outcomes Associated With Non-Evidence-Based Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries (From the National Cardiovascular Data Registry). The American Journal Of Cardiology 2021, 155: 64-71. PMID: 34315569, DOI: 10.1016/j.amjcard.2021.06.020.Peer-Reviewed Original ResearchConceptsPrimary prevention ICD implantationRisk of mortalityICD implantationHeart failureICD RegistryMortality riskNational Cardiovascular Data Registry ICD RegistryPivotal randomized clinical trialsHospital adverse eventsSevere heart failureRecent myocardial infarctionCause hospital readmissionRandomized clinical trialsSimilar mortality riskLongitudinal outcomesImplantable cardioverter defibrillatorGreater mortality riskCause hospitalizationCause mortalityCoronary revascularizationAdverse eventsHospital readmissionICD recipientsDevice implantationPrimary preventionPsychological factors and cardiac repolarization instability during anger in implantable cardioverter defibrillator patients
Krantz DS, Harris KM, Rogers HL, Whittaker KS, Haigney MCP, Kop WJ. Psychological factors and cardiac repolarization instability during anger in implantable cardioverter defibrillator patients. Annals Of Noninvasive Electrocardiology 2021, 26: e12848. PMID: 33813750, PMCID: PMC8293621, DOI: 10.1111/anec.12848.Peer-Reviewed Original ResearchConceptsQT variability indexCoronary artery diseaseCardiac repolarization instabilityICD patientsAnger recallArrhythmic vulnerabilityRepolarization instabilityRepolarization labilityHighest QT variability indexImplantable cardioverter defibrillator patientsCardiac repolarization labilitySudden cardiac deathCardioverter-defibrillator patientsImplantable cardioverter defibrillatorArtery diseaseCardiac deathICD groupMalignant arrhythmiasDefibrillator patientsHealthy controlsContinuous ECGCardioverter defibrillatorPatientsSelf-rated angerAcute anger
2020
Trends in Use and In-Hospital Outcomes of Subcutaneous Implantable Cardioverter Defibrillators in Patients Undergoing Long-Term Dialysis
Pun PH, Parzynski CS, Friedman DJ, Sanders G, Curtis JP, Al-Khatib SM. Trends in Use and In-Hospital Outcomes of Subcutaneous Implantable Cardioverter Defibrillators in Patients Undergoing Long-Term Dialysis. Clinical Journal Of The American Society Of Nephrology 2020, 15: 1622-1630. PMID: 32967922, PMCID: PMC7646229, DOI: 10.2215/cjn.07920520.Peer-Reviewed Original ResearchConceptsHospital cardiac arrestSubcutaneous ICDTransvenous ICDICD implantsHospital outcomesICD recipientsICD RegistryCardiac arrestHigh riskNational Cardiovascular Data Registry ICD RegistryFirst-time ICD recipientsPropensity score-weighted analysisImplantable cardioverter defibrillator implantationSubcutaneous implantable cardioverter defibrillatorIn-Hospital OutcomesShort-term complicationsCardioverter-defibrillator implantationLong-term dialysisVascular access siteImplantable cardioverter defibrillatorCause deathHospital complicationsHospital stayDefibrillator implantationUS patientsSex-Specific Outcomes in Cardiovascular Device Evaluations
Ghare MI, Tirziu D, Abbott JD, Altin E, Yang Y, Ng V, Grines C, Lansky A. Sex-Specific Outcomes in Cardiovascular Device Evaluations. Journal Of Women's Health 2020, 29: 1246-1255. PMID: 32543268, PMCID: PMC9545802, DOI: 10.1089/jwh.2019.8068.Peer-Reviewed Original ResearchConceptsCoronary revascularizationHeart failureClinical trialsDevice trialsMajor clinical trialsStructural heart diseaseSex-specific outcomesBenefit/risk assessmentCardiac resynchronization defibrillatorImplantable cardioverter defibrillatorVentricular assist deviceBest available careDrug eluting stentsBetter treatment recommendationsCardiovascular outcomesDevice therapyTreatment recommendationsHeart diseaseCardioverter defibrillatorDevice clinical trialsTreatment selectionAvailable careAssist deviceNarrative reviewEluting stents8 Anger and long-term mortality and ventricular tachyarrhythmias in patients with a first-time implantable cardioverter defibrillator
Pedersen S, Andersen C, Burg M, Theuns D. 8 Anger and long-term mortality and ventricular tachyarrhythmias in patients with a first-time implantable cardioverter defibrillator. Journal Of Psychosomatic Research 2020, 133: 109999. DOI: 10.1016/j.jpsychores.2020.109999.Peer-Reviewed Original ResearchOUTCOMES OF SPORTS PARTICIPATION FOR PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY AND IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS: DATA FROM THE ICD SPORTS REGISTRY
Maron B, Daimee U, Olshansky B, Cannom D, Heidbuchel H, Salberg L, Ackerman M, Carre F, Estes N, Law I, Link M, Saarel E, Wilhelm M, Gan G, Lampert R. OUTCOMES OF SPORTS PARTICIPATION FOR PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY AND IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS: DATA FROM THE ICD SPORTS REGISTRY. Journal Of The American College Of Cardiology 2020, 75: 305. DOI: 10.1016/s0735-1097(20)30932-3.Peer-Reviewed Original ResearchImplantable cardioverter defibrillatorHypertrophic cardiomyopathyCardioverter defibrillatorSports participationPatientsCardiomyopathyRegistry
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply